10X Genomics, Inc. (TXG)
53.40
-3.98
(-6.94%)
USD |
NASDAQ |
Nov 20, 14:07
10X Genomics Price : 53.40 for Nov. 20, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 59.18 | 61.74 | 56.96 | 57.38 | 2.318M |
| Nov 18, 2026 | 57.05 | 58.22 | 55.38 | 57.07 | 2.096M |
| Nov 17, 2026 | 55.47 | 56.73 | 52.67 | 56.30 | 2.866M |
| Nov 16, 2026 | 54.80 | 56.52 | 54.46 | 54.99 | 3.180M |
| Nov 13, 2026 | 59.50 | 59.50 | 56.32 | 58.19 | 2.126M |
| Nov 12, 2026 | 57.87 | 60.37 | 53.00 | 59.10 | 2.741M |
| Nov 11, 2026 | 66.50 | 68.94 | 61.98 | 62.05 | 1.755M |
| Nov 10, 2026 | 64.11 | 66.16 | 61.42 | 62.90 | 2.474M |
| Nov 09, 2026 | 60.46 | 66.46 | 59.41 | 65.05 | 2.773M |
| Nov 06, 2026 | 57.89 | 61.99 | 55.50 | 59.28 | 4.523M |
| Nov 05, 2026 | 61.64 | 63.40 | 57.19 | 58.06 | 5.969M |
| Nov 04, 2026 | 68.24 | 68.32 | 62.88 | 67.52 | 2.924M |
| Nov 03, 2026 | 63.21 | 66.19 | 62.51 | 65.29 | 2.631M |
| Nov 02, 2026 | 70.31 | 71.00 | 61.24 | 61.63 | 5.174M |
| Oct 30, 2026 | 73.65 | 75.79 | 67.42 | 70.11 | 5.219M |
| Oct 29, 2026 | 82.12 | 84.40 | 80.08 | 81.55 | 1.860M |
| Oct 28, 2026 | 78.93 | 87.82 | 78.25 | 83.62 | 5.047M |
| Oct 27, 2026 | 72.81 | 79.35 | 72.31 | 78.02 | 2.129M |
| Oct 26, 2026 | 70.81 | 74.45 | 70.81 | 72.96 | 1.413M |
| Oct 23, 2026 | 68.94 | 71.83 | 67.52 | 71.55 | 2.228M |
| Oct 22, 2026 | 73.85 | 75.59 | 67.25 | 69.75 | 4.190M |
| Oct 21, 2026 | 70.92 | 77.55 | 70.10 | 75.59 | 3.125M |
| Oct 20, 2026 | 69.52 | 73.40 | 67.53 | 71.46 | 2.861M |
| Oct 19, 2026 | 71.48 | 72.48 | 68.50 | 69.89 | 2.527M |
| Oct 16, 2026 | 71.91 | 73.99 | 67.52 | 69.86 | 3.387M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Twist Bioscience Corp. | 105.53 |
| Tempus AI, Inc. | 55.27 |
| Intellia Therapeutics, Inc. | 10.25 |
| Personalis, Inc. | 14.40 |
| Alamar Biosciences, Inc. (California) | 26.88 |
Price Related Metrics
| PS Ratio | 11.14 |
| Price to Book Value | 8.379 |
| Price to Free Cash Flow | 73.48 |
| Earnings Yield | -0.97% |
| Market Cap | 7.021B |